Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | RGEN | TERN | ||
| Company | Protagonist Therapeutics Inc | Repligen Corp | Terns Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 103.72 | 117.23 | 52.73 | ||
| High | 104.00 | 118.00 | 52.80 | ||
| Low | 101.84 | 114.97 | 52.70 | ||
| Latest | 103.42 | 117.06 | 52.79 | ||
| Change | -0.36 | -0.72 | +0.07 | ||
| % Change | -0.35% | -0.61% | +0.13% | ||
| Volume | 96,411 | 124,000 | 2,257,313 | ||
| 20-Day Average Volume | 952,829 | 938,367 | 9,264,387 | ||
| Previous Close | 103.78 | 117.78 | 52.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 99.47 | 116.70 | 49.37 | ||
| 20-Day Raw Stochastic | 70.63% | 36.78% | 96.48% | ||
| 20-Day Relative Strength | 60.05 | 40.74 | 72.58 | ||
| Weighted Alpha | +111.84 | -12.87 | +785.26 | ||
| Today's Opinion | 100% Buy | 72% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 72% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.84% since 03/27/26 | +6.04% since 03/27/26 | -0.26% since 03/27/26 | ||
| Low | 98.08 on 03/30/26 | 110.50 on 03/30/26 | 52.65 on 04/02/26 | ||
| High | 107.84 on 04/01/26 | 121.72 on 04/02/26 | 52.96 on 03/30/26 | ||
| 1-Month | |||||
| %Chg | +11.60% since 03/06/26 | -2.68% since 03/06/26 | +23.27% since 03/06/26 | ||
| Low | 90.58 on 03/18/26 | 109.66 on 03/27/26 | 41.70 on 03/09/26 | ||
| High | 107.84 on 04/01/26 | 129.00 on 03/10/26 | 53.19 on 03/26/26 | ||
| 3-Month | |||||
| %Chg | +24.92% since 01/06/26 | -32.21% since 01/06/26 | +37.75% since 01/06/26 | ||
| Low | 77.00 on 02/23/26 | 109.66 on 03/27/26 | 33.43 on 01/12/26 | ||
| High | 107.84 on 04/01/26 | 175.00 on 01/07/26 | 53.19 on 03/26/26 | ||
| 6-Month | |||||
| %Chg | +60.23% since 10/06/25 | -22.20% since 10/06/25 | +526.16% since 10/06/25 | ||
| Low | 62.24 on 10/07/25 | 109.66 on 03/27/26 | 6.99 on 10/22/25 | ||
| High | 107.84 on 04/01/26 | 175.77 on 01/06/26 | 53.19 on 03/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,622,097 | 6,634,665 | 6,084,574 | ||
| Shares Outstanding, K | 63,809 | 56,331 | 115,413 | ||
| Annual Sales | 46,020,000 | 738,260,000 | 0 | ||
| Annual Net Income | -130,150,000 | 48,890,000 | -88,850,000 | ||
| Last Quarter Sales | 7,440,000 | 197,910,000 | 0 | ||
| Last Quarter Net Income | -44,380,000 | 13,290,000 | -24,640,000 | ||
| 60-Month Beta | 2.12 | 1.19 | -0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.69 on 02/25/26 | 0.49 on 02/24/26 | -0.27 on 11/10/25 | ||
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 69.19 | 0.00 | ||